Living with Atrial Fibrillation: An Analysis of Patients' Perspectives

Altıok, Meral; Yılmaz, Mualla; Rencüsoğullari, Ibrahim

doi:10.1016/j.anr.2015.10.001

Cited by 22 publications

(49 citation statements)

References 29 publications

(46 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The few qualitative studies that have been conducted on persons with AF reveal some illness beliefs in their results, even though they have not explicitly investigated such beliefs. In agreement, the studies of Altiok et al (2015) and McCabe et al (2011b) report the beliefs of persons with AF as expressing a need to incorporate and normalise AF into daily life.…”

Section: Previous Studies On Illness Beliefs In Afmentioning

confidence: 79%

“…, Altiok et al . ). Even though the present study also found that AF imposed limitations and restrictions on daily life, they were not regarded with profound pessimism.…”

Section: Discussionmentioning

confidence: 97%

“…In agreement, the studies of Altiok et al . () and McCabe et al . () report the beliefs of persons with AF as expressing a need to incorporate and normalise AF into daily life.…”

Section: Introductionmentioning

confidence: 87%

See 2 more Smart Citations

The heart is a representation of life: an exploration of illness beliefs in couples living with atrial fibrillation

Dalteg

Sandberg

Malm

et al. 2017

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

Section: Previous Studies On Illness Beliefs In Afmentioning

confidence: 79%

“…, Altiok et al . ). Even though the present study also found that AF imposed limitations and restrictions on daily life, they were not regarded with profound pessimism.…”

Section: Discussionmentioning

confidence: 97%

See 1 more Smart Citation

The heart is a representation of life: an exploration of illness beliefs in couples living with atrial fibrillation

Dalteg

Sandberg

Malm

et al. 2017

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

“…Patients with AF on VKA face limitations in their activities of daily living and social lives due to frequent monitoring, clinic visits, bleeding leading to frequent hospitalizations, and lifestyle or dietary restrictions that ultimately impact health‐related QoL. Furthermore, the use of VKA for stroke prevention in patients with AF has been shown to negatively impact QoL, particularly in those of advanced age …”

Section: Introductionmentioning

confidence: 99%

“…Furthermore, the use of VKA for stroke prevention in patients with AF has been shown to negatively impact QoL, particularly in those of advanced age. 5 Presently, the increasing number of structural cardiovascular interventions and the expected increase of the aging of the population emerges with the fundamental issue of inability to demonstrate an increase in survival as a measurement of treatment success. For the very elderly, QoL may, therefore, represent a better marker.…”

Section: Introductionmentioning

confidence: 99%

Long‐term quality of life in octogenarians and nonagenarians with nonvalvular atrial fibrillation following WATCHMAN™ device implantation

Tuarez

Pino

Alrifai

et al. 2018

Cathet Cardio Intervent

View full text Add to dashboard Cite

Objectives: To assess the impact of WATCHMAN™ on quality of life (QoL) in octogenarians and nonagenarians.Background: QoL after WATCHMAN™ device in the elderly remains unknown.Methods: This is a prospective and retrospective cohort study of patients that underwent WATCHMAN™ implantation in a tertiary cardiovascular center from April 1, 2015 to September 27, 2017. The primary outcome was a prospective assessment of QoL via the SF-12v2 Health Survey (SF-12v2) in those aged ≥80 and ≥90 years. Secondary outcomes include major bleeding, stroke, vascular complications, pericardial effusion, device related thrombus (DRT), prolonged length of stay (LOS), acute kidney injury (AKI), and recurrent hospitalizations. Results: This cohort of 151 patients included 48/151 (32%) females with a mean age of 80 AE 7.7 years. Mean CHA 2 DS 2 -VASc was 4.38 AE 1.36 and mean HAS-BLED was 3.27 AE 1.17. Octogenarians 65/81(80%) and nonagenarians 16/81(20%) comprised 81/151(54%) of patients (mean age 86 AE 4.3 years) from which 36/65 (55%) octogenarians and 10/16 (63%) nonagenarians completed SF-12v2 evaluation at 22 AE 10 and 30 AE 10-months. Octogenarians demonstrated enhanced physical component scores (PCS), and nonagenarians equal PCS versus the age-adjusted norm (45.43 AE 9.84 versus 38.68 AE 11.04, P = 0.0003, and 41.26 AE 12.36 versus 38.68 AE 11.04, P = 0.6463, respectively). The mental component scores (MCS) of octogenarians and nonagenarians remained comparable (51.80 AE 9.56 and 48.97 AE 9.92 versus 50.06 AE 10.94, respectively, P = 0.4659). No stroke, vascular complications, pericardial effusions, or readmissions related to WATCHMAN™ occurred. No difference among patients <80, ≥80, and ≥90 years was found in major bleeding events, DRT, prolonged LOS, or AKI (P = 0.0569, 0.116, 0.498, and 0.795, respectively).Conclusions: Octogenarians and nonagenarians experience favorable long-term QoL after WATCHMAN™, with acceptable bleeding risk and low incidence of procedure-related complications. K E Y W O R D Sbleeding, elderly patients, left atrial appendage closure, stroke

show abstract

Experiences of living with symptomatic atrial fibrillation

et al. 2022

View full text Add to dashboard Cite

Atrial fibrillation (AF) is the most common arrhythmia. In 2010, more than 33.5 million people worldwide were estimated to be affected and the disease continues to increase in both prevalence and incidence (Chugh et al., 2014). Increased prevalence is due to both improved awareness of AF resulting in systematic diagnosis of AF being made earlier (Kirchhof, Breithardt, et al., 2016) and increases in the life expectancy of the general population (Hindricks et al., 2020).Age is a major risk factor for AF, along with other factors that can be modified by lifestyle changes, namely high blood pressure, high cholesterol levels, diabetes, obesity and obstructive sleep apnoea syndrome (Hindricks et al., 2020). | BACKG ROU N DThe risk of AF for people of European descent and over the age of 55 is 1 in 3 (Hindricks et al., 2020). In Sweden, about 330,000 persons live with the diagnosis of AF (Riksförbundet HjärtLung, 2021).Since many individuals have asymptomatic AF and/or are undiagnosed, prevalence, in general, is assumed to be significantly higher (Kirchhof, Benussi, et al., 2016). Symptoms for those affected vary; some have no symptoms at all while others experience severe symptoms with a large symptom burden. Common symptoms are palpitations, shortness of breath and fatigue (Hindricks et al., 2020).Research shows that AF negatively affects health-related quality of life (HRQoL), often in relation to the severity of symptoms (Freeman

show abstract

Living with Atrial Fibrillation: An Analysis of Patients' Perspectives

Cited by 22 publications

References 29 publications

The heart is a representation of life: an exploration of illness beliefs in couples living with atrial fibrillation

The heart is a representation of life: an exploration of illness beliefs in couples living with atrial fibrillation

Long‐term quality of life in octogenarians and nonagenarians with nonvalvular atrial fibrillation following WATCHMAN™ device implantation

Experiences of living with symptomatic atrial fibrillation

Contact Info

Product

Resources

About